252
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

The Squid Ink Polysaccharides Protect Tight Junctions and Adherens Junctions from Chemotherapeutic Injury in the Small Intestinal Epithelium of Mice

, , , , &
Pages 364-371 | Received 06 Feb 2014, Accepted 10 Oct 2014, Published online: 14 Jan 2015

REFERENCES

  • Fasano A: Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. The American Journal of Pathology 173, 1243–1252, 2008.
  • Moens E and Veldhoen M: Epithelial barrier biology: good fences make good neighbours. Immunology 135, 1–8, 2012.
  • Gonzalez-Mariscal L, Betanzos A, Nava P, and Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol 81, 1–44, 2003.
  • Tokes AM, Kulka J, Paku S, Szik A, Paska C, et al.: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7, R296–R305, 2005. doi:10.1186/bcr983
  • Jamora C and Fuchs E: Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 4, E101–E108, 2002. doi:10.1038/ncb0402-e101
  • Yáñez JA, Teng XW, Roupe KA, Fariss MW, and Davies NM: Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J Pharm Pharm Sci 6, 308–314, 2003.
  • Yang J, Liu KX, Qu JM, and Wang XD: The changes induced by cyclophosphamide in intestinal barrier and microflora in mice. Eur J Pharmacol 714, 120–124, 2013. doi:10.1016/j.ejphar.2013.06.006
  • Song D, Shi B, Xue H, Li Y, Yang X, et al.: Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate. Dig Dis Sci 51, 1549–1556, 2006. doi:10.1007/s10620-005-9058-0
  • Song D, Shi B, Xue H, Li Y, Yu B, et al.: Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy. Curr Microbiol 52, 69–73, 2006. doi:10.1007/s00284-005-0177-9
  • Stecher B and Hardt WD: The role of microbiota in infectious disease. Trends Microbiol 16, 107–114, 2008. doi:10.1016/j.tim.2007.12.008
  • Chen S, Wang J, Xue C, Li H, Sun B, et al.: Sulfation of a squid ink polysaccharide and its inhibitory effect on tumor cell metastasis. Carbohydrate Polymers 81, 560–566, 2010.
  • Liu H, Luo P, Chen S, and Shang J: Effects of Squid Ink on Growth Performance, Antioxidant functions and immunity in growing broiler chickens. Asian-Aust J Anim Sci 24, 1752–1756, 2011.
  • Chen S-G, Li Z-J, Wang Y-M, Li G-Y, Sun B-B, et al.: Sulfation of a Squid ink polysaccharide and its anticoagulant activities [J]. Chemical Journal of Chinese Universities 12, 21, 2010.
  • Chen S, Xu J, Xue C, Dong P, Sheng W, et al.: Sequence determination of a non-sulfated glycosaminoglycan-like polysaccharide from melanin-free ink of the squid Ommastrephes bartrami by negative-ion electrospray tandem mass spectrometry and NMR spectroscopy. Glycoconjugate Journal 25, 481–492, 2008.
  • Zuo T, Li X-M, Cao L, Wang J-F, Wang Y-M, et al.: Promotion effect of squid ink polysaccharide on intestinal mucosa immunity in mice. Chinese Pharmacological Bulletin 8, 29, 2013.
  • Cao L, Zuo T, Li X, Yu Q, Cao B, et al.: Protective effects and the mechanism of polysaccharides from the ink of ommastrephes bartrami on the intestinal mucosa of the mice with chemotherapy. Chinese Pharmacological Bulletin 29, 1558–1562, 2013.
  • Resendiz-Albor AA, Reina-Garfias H, Rojas-Hernandez S, Jarillo-Luna A, Rivera-Aguilar V, et al.: Regionalization of pIgR expression in the mucosa of mouse small intestine. Immunol Lett 128, 59–67, 2010. doi:10.1016/j.imlet.2009.11.005
  • Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, et al.: Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119, 2095–2106, 2006. doi:10.1242/jcs.02915
  • Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, et al.: A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123, 163–172, 2002.
  • Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, et al.: Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166, 409–419, 2005.
  • Berglund JJ, Riegler M, Zolotarevsky Y, Wenzl E, and Turner JR: Regulation of human jejunal transmucosal resistance and MLC phosphorylation by Na(+)-glucose cotransport. Am J Physiol Gastrointest Liver Physiol 281, G1487–G1493, 2001.
  • Nusrat A, Turner J, and Madara J: IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 279, G851–G857, 2000.
  • Abraham P and Isaac B: Ultrastructural changes in the rat kidney after single dose of cyclophosphamide—possible roles for peroxisome proliferation and lysosomal dysfunction in cyclophosphamide-induced renal damage. Human & Experimental Toxicology 30, 1924–1930, 2011.
  • Palumbo A and Rajkumar SV: Multiple myeloma: chemotherapy or transplantation in the era of new drugs. European journal of haematology 84, 379–390, 2010.
  • Watanabe Y, Etoh T, Koike E, Mizuno Y, Wang W-M, et al.: Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer. International Journal of Clinical Oncology 15, 468–471, 2010.
  • Laurenti L, De Padua L, Tarnani M, Piccirillo N, Falcucci P, et al.: Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome. Annals of Hematology 90, 59–65, 2011.
  • Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, et al.: Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. Journal of Applied Microbiology 104, 672–680, 2008
  • Owari M, Wasa M, Oue T, Nose S, Fukuzawa M: Glutamine prevents intestinal mucosal injury induced by cyclophosphamide in rats. Pediatr Surg Int 28, 299–303, 2012. doi: 10.1007/s00383-011-3023-0
  • Suzuki T, Yoshinaga N, Tanabe S: Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286, 31263–31271, 2011. doi:10.1074/jbc.M111.238147
  • Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F, et al.: Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-alpha on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 304, G970–G979, 2013. doi:10.1152/ajpgi.00183.2012
  • Gu L, Li N, Yu W, Gong J, Li Q, et al.: Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis. Am J Chin Med 41, 1297–1312, 2013. doi: 10.1142/S0192415X13500870
  • Kim CY and Kim KH: Curcumin prevents leptin-induced tight junction dysfunction in intestinal Caco-2 BBe cells. J Nutr Biochem 25, 26–35, 2014. doi:10.1016/j.jnutbio.2013.08.011
  • Peng SN, Zeng HH, Fu AX, Chen XW, and Zhu QX: Effects of rhein on intestinal epithelial tight junction in IgA nephropathy. World J Gastroenterol 19, 4137–4145, 2013. doi:10.3748/wjg.v19.i26.4137
  • Wang HB, Wang PY, Wang X, Wan YL, and Liu YC: Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci 57, 3126–3135, 2012. doi:10.1007/s10620-012-2259-4
  • Zhao Y, Qin G, Sun Z, Che D, Bao N, et al.: Effects of soybean agglutinin on intestinal barrier permeability and tight junction protein expression in weaned piglets. Int J Mol Sci 12, 8502–8512, 2011. doi:10.3390/ijms12128502
  • Suzuki T and Hara H: Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem 22, 401–408, 2011. doi:10.1016/j.jnutbio.2010.08.001
  • Gonzalez-Mariscal L, Betanzos A, Nava P, and Jaramillo B: Tight junction proteins. Progress in Biophysics and Molecular Biology 81, 1–44, 2003.
  • Kawabe H, Nakanishi H, Asada M, Fukuhara A, Morimoto K, et al.: Pilt, a novel peripheral membrane protein at tight junctions in epithelial cells. Journal of Biological Chemistry 276, 48350–48355, 2001.
  • Han X, Fink MP, Uchiyama T, Yang R, Delude RL: Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Lung Cell Mol Physiol 286, L259–L267, 2004. doi:10.1152/ajplung.00187.2003
  • Schepetkin IA, Quinn MT: Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 6, 317–333, 2006. doi:10.1016/j.intimp.2005.10.005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.